Popularity of synthetic cannabinoids among US military service members has risen over the last several years, leading to an increase in hospitalizations and legal actions stemming from its use and possession. Although synthetic cannabinoids, collectively referred to as “Spice,” are similar in structure to the active metabolites found in cannabis, significant concerns exist regarding the severity of short- and long-term medical and psychiatric sequelae. This article presents a case, in which a patient experienced severe medical and psychiatric symptoms far exceeding the severity and duration typically resulting from cannabis use.
The European Monitoring Centre for Drugs and Drug Addiction. 2009. Understanding the ‘Spice’ Phenomenon, Luxembourg: The European Monitoring Centre for Drugs and Drug Addiction.
2.
MöllerI, WintermeyerABenderK. 2011;3(9):609–620. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Testing and Analysis,
3.
FlorA. 2010. Spice—“I want a new drug.. The Army Lawyer, : 23–25.
4.
IversenL.2003. Cannabis and the brain. Brain, 126: 1252–1270
5.
AmesF.1958. A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. Br J Psychiatry, 104: 972–999.
6.
TalbottJ A and TeagueJ W. 1969. Marihuanann psychosis: acute toxic psychosis associated with the use of cannabis derivatives. JAMA, 210: 299–302.
7.
TennantF SJr and GroesbeckC J. 1972. Psychiatric effects of hashish. Arch Gen Psychiatry, 27: 133–136.
8.
ChopraG S and SmithJ W. 1974. Psychotic reactions following cannabis use in East Indians. Arch Gen Psychiatry, 30: 24–27.
